[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
IBN (InvestorBrandNetwork) @IBNMediaNetwork on x 5174 followers
Created: 2025-07-18 19:07:02 UTC
Lantern Pharma (NASDAQ: $LTRN) just dropped a major AI breakthrough in cancer treatment! 🚨
Their new AI-powered module, built from XXX clinical trials, is now part of Lantern’s RADR® platform and focuses on predicting the best drug combinations for cancer patients. Why it matters:
💥 Targets a $50B+ market in combo cancer therapies 💥 Over XX% of cancer patients receive the types of treatments this AI optimizes 💥 Already helped design an FDA-cleared breast cancer trial 💥 Aims to cut drug development costs and timelines by 1/3
Simply put: Lantern is using AI to personalize cancer care and speed up life-saving treatments.
👉 Follow $LTRN for updates as they expand this game-changing tech.
Read more:
XX engagements
Related Topics combo $50b aipowered breakthrough coins ai $ltrn nasdaq